3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Mycophenolic Acid
17
fludarabine phosphate
16
Cyclophosphamide
15
Whole-Body Irradiation
10
Tacrolimus
10
Melphalan
10
Peripheral Blood Stem Cell Transplantation
9
Filgrastim
9
Cyclosporine
9
Busulfan
9
Antilymphocyte Serum
8
Granulocyte Colony-Stimulating Factor
7
thymoglobulin
6
Methotrexate
6
Cord Blood Stem Cell Transplantation
5
fludarabine
4
Thiotepa
4
Radiotherapy
4
Methylprednisolone
4
Etoposide
4
Cytarabine
4
Stem Cell Transplantation
3
Rituximab
3
Clofarabine
3
Transplantation
2
Sirolimus
2
Methylprednisolone Hemisuccinate
2
Methylprednisolone Acetate
2
Etanercept
2
Alemtuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelomonocytic, Juvenile
×
Imatinib Mesylate
×
Clear all
No trials found.